Cerebral iron accumulation in multiple sclerosis: Pathophysiology and therapeutic implications

Area of Science:

• Neuroscience
• Immunology
• Biochemistry

Background:

• Multiple sclerosis (MS) is a central nervous system autoimmune disorder involving demyelination, neuroinflammation, and neurodegeneration.
• Cerebral iron (Fe) accumulation is increasingly recognized as a key factor exacerbating MS pathophysiology.
• Dysregulated iron contributes to oxidative stress and inflammation, particularly in gray matter and demyelinated lesions.

Purpose of the Study:

• To explore the role of cerebral iron accumulation in multiple sclerosis.
• To investigate the mechanisms by which iron influences neuroinflammation and neurodegeneration in MS.
• To evaluate the therapeutic potential of targeting iron metabolism in MS treatment.

Main Methods:

• Utilized advanced neuroimaging techniques like susceptibility-weighted imaging and quantitative susceptibility mapping to detect abnormal iron deposition in MS patients.
• Examined the interaction between iron and immune cells, specifically microglia, to understand its role in cytokine release and neuroinflammation.
• Reviewed existing and emerging therapeutic strategies targeting iron metabolism, including iron chelation and nanotherapeutics.

Main Results:

• Abnormal iron deposition patterns were identified in the brains of MS patients using advanced imaging.
• Iron accumulation was linked to increased oxidative stress, neuroinflammation, and neuronal damage via microglial activation.
• Iron dysregulation contributes to clinical symptoms such as cognitive impairment in MS.

Conclusions:

• Cerebral iron dysregulation is a significant driver of multiple sclerosis progression.
• Therapeutic strategies targeting iron metabolism, such as chelation and nanotherapeutics, show promise but face challenges like blood-brain barrier penetration.
• Further research into the molecular mechanisms of iron-induced neuroinflammation is crucial for developing effective MS interventions.